Celera (NASDAQ:CRA) today reported net revenues of $45.8 million for the third quarter of calendar 2008 that ended September 27, 2008, compared to $16.1 million in the prior year quarter. The third quarter calendar 2008 results included net revenues from Berkeley HeartLab, Inc.

Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that RiskMetrics Group, formerly known as Institutional Shareholder Services, or ISS, Glass Lewis & Co.

Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the appointment of Peter G. Amanatides as Vice President - Quality Assurance & Quality Control, effective immediately. In this role, Amanatides will lead all aspects of Noven's quality functions.

Scientists conducting stem cell research are convening at symposia in mid-September in Connecticut and New Jersey to share best practices, drive standardization to advance science, and enable greater collaboration.

Applied Biosystems Inc. (NYSE:ABI) today announced it has set the date for a special meeting of its shareholders to consider the proposed merger with Invitrogen Corporation. The special meeting of shareholders will be held on October 16, 2008, at 9:30 a.m. EDT.